Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT00458146

Public ClinicalTrials.gov record NCT00458146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 11:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 60mg of MM-093 Versus Placebo in Patients With Active Rheumatoid Arthritis on Stable Doses of Methotrexate

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether MM-093 is safe and effective in the treatment of RA.

Study identification

NCT ID
NCT00458146
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merrimack Pharmaceuticals
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2007 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Mar 27, 2008

Started 2007

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Montgomery Rheumatology Associates Montgomery Alabama 36111 —
East Valley Rheumatology & Osteoporosis Gilbert Arizona 85234 —
Radiant Research Scottsdale Arizona 85251 —
Arthritis Medical Center of the Central Coast Santa Maria California 93454 —
National Jewish Medical and Research Center Denver Colorado 80206 —
Denver Arthritis Clinic Denver Colorado 80230 —
New England Research Associates Trumbull Connecticut 06611 —
Arthritis and Rheumatic Disease Specialties Aventura Florida 33180 —
Paddock Park Clinical Research Ocala Florida 34474 —
Arthritis Research of Florida, Inc. Palm Harbor Florida 34684 —
Sarasota Arthritis Research Center Sarasota Florida 34239 —
Illinois Bone & Joint Institute Morton Grove Illinois 60053 —
Wichita Clinic Wichita Kansas 67208 —
Arthritis Center of Nebraska Lincoln Nebraska 68516 —
Arthritis Center of Reno Reno Nevada 89502 —
Arthritis Center and Carolina Bone and Joint Charlotte North Carolina 28210 —
East Pennsylvania Rheumatology Association Bethlehem Pennsylvania 18015 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Rheumatology and Internal Medicine Amarillo Texas 79106 —
University of Utah Division of Rheumatology Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00458146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2008 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00458146 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →